Broad-spectrum fluoroquinolone indicated for the management of diseases associated with bacteria susceptible to enrofloxacin.
Targets gram-positive and gram-negative bacteria, including those causing dermal, urinary and respiratory tract infections.
Chewable tablets are double scored for accurate dosing. For dogs and cats.